With entrepreneur-friendly government regulation and high-quality late stage companies on the cusp of going public, VCs expect to see solid returns in the coming year.
Software deals were up, but biotech and cleantech investments declined.
Venture capital funds raised $4.9 billion in the first quarter of 2012, down 35 percent from a year ago, according to Thomson Reuters and the National Venture Capital Association.
Venture Capital deals in the third quarter of 2011 dropped 12 percent in dollars invested compared to last quarter. Clean technology and life sciences industries were particularly hard hit, according to a report released today by PricewaterhouseCoopers and the National Venture Capital Association.